Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pet Pharm Biotech CoROCO:7762 +0.20%19 Dividend Payout Ratio is 0.30 as of Dec. 2025, which is 17% below its 10-year median of 0.36. GuruFocus rates ROCO:7762 with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 445 Drug Manufacturers companies, Pet Pharm Biotech Co ranks better than 77.75% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Pet Pharm Biotech Co's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.30.
The historical rank and industry rank for Pet Pharm Biotech Co's Dividend Payout Ratio or its related term are showing as below:
ROCO:7762'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.19 Med: 0.36 Max: 0.53
Current: 0.19
During the past 4 years, the highest Dividend Payout Ratio of Pet Pharm Biotech Co was 0.53. The lowest was 0.19. And the median was 0.36.
ROCO:7762's Dividend Payout Ratio is ranked better than 77.75% of 445
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs ROCO:7762: 0.19
During the past 12 months, Pet Pharm Biotech Co's average Dividends Per Share Growth Rate was -53.20% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Pet Pharm Biotech Co (ROCO:7762) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Pet Pharm Biotech Co Dividend Payout Ratio Related Terms
Pet Pharm Biotech Co Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Pet Pharm Biotech Co's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7762 vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison
For the Drug Manufacturers - General subindustry, Pet Pharm Biotech Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pet Pharm Biotech Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pet Pharm Biotech Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Pet Pharm Biotech Co's Dividend Payout Ratio falls into.
Pet Pharm Biotech Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Pet Pharm Biotech Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pet Pharm Biotech Co (ROCO:7762) has a Dividend Payout Ratio of 0.30 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Pet Pharm Biotech Co and its competitors. This is 17% below median its historical median of 0.36. Over the past decade, Pet Pharm Biotech Co's Dividend Payout Ratio has ranged from 0.19 to 0.53. According to the industry distribution chart, Pet Pharm Biotech Co ranks #99 out of 445 companies in the Drug Manufacturers industry, placing it in the top 22.2%.
Is Pet Pharm Biotech Co's Dividend Payout Ratio too high?
Pet Pharm Biotech Co's current Dividend Payout Ratio of 0.30 is 17% below median its 10-year median of 0.36. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 0.53. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Pet Pharm Biotech Co's value of 0.30 is 21.1% below this industry median. Based on the distribution chart, Pet Pharm Biotech Co ranks #99 out of 445 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Pet Pharm Biotech Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pet Pharm Biotech Co's Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Pet Pharm Biotech Co ranks #99 out of 445 companies for Dividend Payout Ratio. This places Pet Pharm Biotech Co in the top 22% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. Pet Pharm Biotech Co's value of 0.30 is 21.1% below this benchmark. Historically, Pet Pharm Biotech Co's own Dividend Payout Ratio has ranged from 0.19 to 0.53 over the past decade. While the company's 10-year median is 0.36 vs. the industry median of 0.38, Pet Pharm Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pet Pharm Biotech Co's current Dividend Payout Ratio of 0.30 is 21.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Pet Pharm Biotech Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pet Pharm Biotech Co's current Dividend Payout Ratio is 0.30, which is 17% below median its own 10-year median of 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pet Pharm Biotech Co stock overvalued right now?
Pet Pharm Biotech Co (ROCO:7762) has a current Dividend Payout Ratio of 0.30. The current Dividend Payout Ratio is 0.30, which is 17% below median its 10-year median of 0.36 and 21.1% below the Drug Manufacturers industry median of 0.38. Pet Pharm Biotech Co's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Pet Pharm Biotech Co (ROCO:7762), the current Dividend Payout Ratio is 0.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.
19GF Score
Get the complete analysis for ROCO:7762
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7762 has been successfully added to your 
